Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
04 févr. 2019 08h30 HE
|
Hemostemix Inc.
CALGARY, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) a biotechnology company focused on developing and commercializing...
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
24 janv. 2019 10h00 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
New Medical Breakthroughs from International Scientists and Doctors in Stem Cells and Regenerative Medicine
22 janv. 2019 11h20 HE
|
Regenerative Medicine Foundation & Phacilitate Leaders World
Miami, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- There is only one place in the world to interview and learn from all of the critical decision-makers from every stakeholder in the exploding field of...
The Alliance for Regenerative Medicine Releases Initial Slate of Presenting Companies at the 2019 Inaugural Cell & Gene Meeting on the Mediterranean
17 janv. 2019 10h02 HE
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and...
Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results
17 janv. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, February 7, 2019 at 5:00 p.m. Eastern Time (ET) to discuss...
3Scan Hosts San Francisco Biotech Showcase with Prellis Biologics and Announces Real Human Tissue Structures for R&D Bioprinting with the Holograph-X
07 janv. 2019 19h22 HE
|
3Scan
San Francisco, Jan. 07, 2019 (GLOBE NEWSWIRE) -- 3Scan, the world’s leading 3D tissue imaging company and creators of the largest high-resolution vascular tissue data sets in the world, is hosting a...
3Scan Hosts San Francisco Biotech Showcase with Prellis Biologics and Announces Real Human Tissue Structures for R&D Bioprinting with the Holograph-X
07 janv. 2019 19h11 HE
|
3Scan
San Francisco, Jan. 07, 2019 (GLOBE NEWSWIRE) -- 3Scan, the world’s leading 3D tissue imaging company and creators of the largest high-resolution vascular tissue data sets in the world, is hosting a...
Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial
03 janv. 2019 08h00 HE
|
Hemostemix Inc.
CALGARY, Alberta, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from two...
BioStem Technologies Releases Third Quarter 2018 Shareholder Update
10 déc. 2018 11h48 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...
Organovo Appoints New Board Member
06 déc. 2018 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...